Safety and effectiveness study of new injection in healthy adults
Part of Hormones & metabolism clinical trials.
This study tests a new experimental injection in healthy volunteers to see if it's safe and how well the body absorbs it. Researchers will compare it with other similar treatments to understand how it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 19 and 65 years old
- Weight between 110–220 lbs (50–100 kg) and BMI between 20–29.9
- No serious medical conditions like heart disease, diabetes, liver problems, or kidney disease
- Not pregnant, breastfeeding, or planning to become pregnant during the study
- No history of severe allergies to GLP-1 drugs or similar medications
- No history of pancreatitis, thyroid cancer, or family history of MEN2 syndrome
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection (GZR102) compared to two other injections (GZR4 and GZR18) in overweight adults. The goal is to see how well the body processes each drug and their effects. It may help researchers find a better treatment for weight management.
This trial tests an investigational injection called MWN109 to see if it is safe and how the body processes it. It is for healthy adults only, and the results will help decide if the drug should be tested in people with medical conditions.
This trial tests a new injection called SYH2092 in healthy adults, not for treating a disease. Participation helps researchers understand how the drug works in the body and if it is safe. If you qualify, you may be compensated for your time.
This study tests a new injected medicine to see if it is safe and how it works in people who are overweight or obese, as well as in healthy volunteers. It may help with weight loss, but it is an early-phase trial to check safety first.
This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.
This trial tests an investigational injection called ZT003 to see if it is safe and how the body processes it. It is for healthy volunteers or those who are overweight or obese, to help understand how this treatment might work.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.